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a  b  s  t  r  a  c  t
Dendritic  cells  (DCs)  are  an  attractive  target  for  DNA  vaccines  as  they  are  potent  antigen  presenting  cells.
This  study  demonstrated  how  non-viral  gene  delivery  to DCs involving  complexes  of poly-l-lysine  (PLL)
and  plasmid  DNA  (pDNA)  (polyplexes)  showed  dependence  on  DNA  vector  topology.  DNA  topology  is
of  importance  from  both  production  and regulatory  viewpoints.  In our previous  study  with  CHO  cells
we  demonstrated  that  polyplex  uptake  was  dependent  on  DNA  topology  whereby  complexes  containing
supercoiled  (SC)  pDNA  were  smaller,  more  resistant  to  nucleases  and  more  effectively  condensed  by  PLL
than  open  circular  (OC)  and linear-pDNA  complexes.
In this  study  polyplex  uptake  in  DCs  was  measured  qualitatively  and  quantitatively  by  confocal
microscopy  along  with  gene  expression  studies  and  measurement  of DC phenotype.  PLL  is known  for  its
ability  to  condense  DNA  and  serve  as  an  effective  gene  delivery  vehicle.  Quantiﬁcation  studies  revealed
that  by  1  h  following  uptake  15% (±2.59%  relative  standard  error  [RSE])  of  SC-pDNA  polyplexes  were
identiﬁed  to  be associated  (ﬂuorescent  co-localisation)  with  the  nucleus,  in  comparison  to no  nuclear
association  identiﬁed  for  OC-  and  linear-pDNA  complexes.  By 48  h  following  uptake,  30%  (±1.82%  RSE)
of  SC-pDNA  complexes  associated  with  the  nucleus  in  comparison  to 16%  (±4.40%  RSE)  and  12%  (±6.97%
RSE)  of  OC-  and  linear-pDNA  polyplexes  respectively.  Confocal  microscopy  images  showed  how  DNA
and  PLL  remained  associated  following  uptake  by  dual  labelling.  Polyplex  (containing  20  g  pDNA)  gene
expression  (plasmid  encoded  lacZ  [-galactosidase]  reporter  gene)  in DCs  was  greatest  for  SC-pDNA  poly-
plexes  at  14.12%  unlike  that of OC-  (9.59%)  and  linear-pDNA  (7.43%).  DCs  express  cell surface  markers
which  contribute  towards  antigen  presentation.  Polyplex  gene  expression  did  not  alter  DC phenotype
through  surface  marker  expression.  This  may  be  due  to the  pDNA  dose  employed  (20 g) as  other  studies
have  used  doses  as high  as  200  g pDNA  to  induce  DC  phenotypic  changes.  Although  no  change  in DC
phenotype  occurred,  this  could  be advantageous  in  terms  of  biocompatibility.  Collectively  these  results
indicate  that  DNA  topology  is  an important  parameter  for DC  vector  design,  particularly  pDNA  in  the SC
to DNconformation  in  regards  
. Introduction
Dendritic cells (DCs) are key components of the immune system
hich function by binding and collecting antigens. Following recog-
ition, DCs present the antigen of interest through selective surface
arkers to T-cells in order to activate a speciﬁed immune response
1]. Antigen presentation also stimulates the differentiation of T-
ells to B cells which release antibodies speciﬁc for the antigen of
nterest. It is these functions that researchers aim to exploit in the
roduction of vaccines.
Abbreviations: DCs, dendritic cells; DNA, deoxyribonucleic acid; linear-pDNA,
inear  plasmid DNA; OC, open circular; OC-pDNA, open circular plasmid DNA; pDNA,
lasmid DNA; PLL, poly-l-lysine; SC, supercoiled; SC-pDNA, supercoiled plasmid
NA.
∗ Corresponding author. Tel.: +44 2076792961; fax: +44 2079163943.
E-mail  address: e.keshavarz-moore@ucl.ac.uk (E. Keshavarz-Moore).
264-410X/     © 2012 Elsevier Ltd.  
oi:10.1016/j.vaccine.2011.12.102
Open access under CC BY license.A  vaccination  studies.
© 2012 Elsevier Ltd.  
Non-viral gene delivery to DCs is an attractive approach for DNA
vaccination to elicit immune responses towards encoded antigenic
sequences [2]. Non-viral techniques often entail delivery of nucleic
acids that are bound to a cationic polymer (polycations) resulting
in plasmid DNA (pDNA) – polymer products, known as polyplexes
[3]. Polycations operate by binding and condensing pDNA into
smaller structures thereby facilitating uptake. Poly-l-lysine (PLL)
is a widely used polycation DNA condensing agent which has been
shown to be effective in inducing conﬁned pDNA structures. Ben-
eﬁts offered by PLL over other polycations include the ease and
rapid ability by which it binds with DNA, and versatility to undergo
chemical modiﬁcation allowing successful delivery of genes [4,5].
Key  factors that affect polyplex uptake in DCs should be consid-
ered in regards to vaccine design. One parameter is the inﬂuence
Open access under CC BY license.of pDNA topology. Plasmids naturally confer to a dense compact
form referred to as supercoiled (SC), whereas a single strand nick
can generate an open circular (OC) conformation. Restriction diges-
tion of the double stranded pDNA results in a linearised form [6].
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ew studies have analysed the effect of pDNA topology on poly-
lex gene expression, with some identifying superior reporter gene
xpression for SC-pDNA [6–8]. We  have previously reported DNA
opology dependent uptake of polyplexes within Chinese hamster
vary (CHO) cells [9]. However polyplex uptake and the inﬂuence
f DNA topology in DCs have not been studied in great depth. This
tudy addresses polyplex uptake within DCs to deduce whether
arameters such as pDNA topology affect uptake, gene expression
nd DC phenotype, which are important considerations for vaccine
esign.
. Materials and methods
.1.  Plasmid DNA preparation and puriﬁcation
The plasmid; pSV – 6.8 kb (Promega, Southampton, UK) was
ropagated within Eschericheria coli (E. coli) DH5 cells. Plasmids
ere puriﬁed and quantiﬁed as previously reported by Dhanoya
t al. [9].
.2.  Production of linear and nicked (open circular) plasmids
Puriﬁed supercoiled (SC)-pDNA samples were both nicked and
igested to generate open circular (OC) and linear topologies
espectively. This method was carried out according to our protocol,
reviously reported in Dhanoya et al. [9].
.3. Production of PLL/DNA polyplexes
Plasmids were bound with poly-l-lysine hydrobromide (PLL)
Sigma) of molecular weight, 9600 according to Dhanoya et al. [9]. A
otal volume of 100 l was  used for polyplexes prior to the addition
f cells for transfection.
.4.  Fluorescent tagging of PLL
PLL was labelled with Oregon Green 488, succinimidyl ester
Invitrogen) according to a previous study [10]. Unbound dye was
emoved by spin column puriﬁcation in accordance to the manu-
acturer’s protocol (Invitrogen).
.5.  Labelling of naked pDNA
Naked  pDNA was labelled via the nucleic acid ﬂuorescent stain;
OTO-3 (Dimeric Cyanine Nucleic Acid Stains–Invitrogen) at a ﬁnal
oncentration of 4 M as carried out by Dhanoya et al. [9]. The ﬂu-
rescent stain exhibits excitation and emission spectra of 642 and
60 nm,  respectively for analysis via confocal microscopy.
.6. Generation of human monocyte-derived dendritic cells
This  study was approved by the joint University College Lon-
on/University College London Hospitals National Health Service
rust Human Research Ethics Committee and written informed
onsent was obtained from all participants.
Venous blood was sampled in heparinized tubes. Peripheral
lood mononuclear cells (PBMCs) were obtained by density-
radient centrifugation using Lymphoprep (Axis-Shield). Mono-
ytes were isolated through magnetic positive selection using
D14 MACS MicroBeads (Miltenyi Biotech) according to manu-
acturer’s instructions. After puriﬁcation the isolated cells were
95% CD14+ cells. Cultures were established in RMPI-1640 (Gibco)
upplemented with 10% (v/v) heat-inactivated fetal bovine serum
FBS) (PAA laboratories), 100 U/ml penicillin/streptomycin (Gibco),
00 ng/ml recombinant human GM-CSF and 50 ng/ml rhIL-4 (both
ifts from Schering-Plough Research Institute, Kenilworth, NJ).0 (2012) 1675– 1681
Dendritic  cells were harvested after 4–7 days culture and were
greater than 90%CD1a positive.
3. Reverse transfection of DCs
Polyplexes were spotted (each spot contained either 2 g pDNA
for confocal microscopy analysis or 20 g pDNA for gene expression
studies [total DNA mass as deduced from nanodrop spectropho-
tometer analysis]) on PLL (50 g/ml) coated 22 ×22 mm coverslips
(VWR International) for 1 h at room temperature in the dark.
Approximately 1 ×106 DCs were seeded in DC differentiation
media on the PLL coated coverslips and incubated at 37 ◦C for
the desired time within 6-well plates (Helena Biosciences). Subse-
quently media was aspirated and replaced with fresh media lacking
serum and incubated at 37 ◦C. Following the desired duration of
transfection, samples were extracted and media aspirated. Cells
were washed once with HBSS. Subsequently cells were treated with
1 ml  3.8% paraformaldehyde and incubated for 15 min. This was
followed by washing with PBS. In regards to confocal microscope
analysis, coverslips were removed and mounted onto a microscope
slide with DAPI mounting medium (Vectashield). In the case of
transfected samples which were to be analysed by ﬂow cytometry,
samples were processed in BD FACS Calibur tubes (BD FACSCal-
ibur) whereby washing steps entailed centrifugation at 1400 rcf for
5 min.
3.1.  Labelling of DCs
DCs  were stained following transfection with HCS CellMaskTM
Stains (Invitrogen) for a period of 30 min  according to the manufac-
ture’s protocol. The stain displays excitation and emission spectra
of 556 and 572 nm respectively.
3.2. Gene expression analysis
DCs  seeded in 6-well plates (Helena Biosciences) were reverse
transfected with polyplexes containing 20 g DNA for 48 h. Sub-
sequently cells were analysed for -galactosidase expression.
Expression was detected using a colorimetric -Gal Assay Kit (Invit-
rogen). The number of blue cells detected under a light microscope
in 5 ﬁelds of view was  expressed as a percentage of total cells.
3.3.  Confocal microscopy
A  Leica SP2 confocal microscope was  used to view cells that
were mounted on the appropriate slides. Fluorescence images
were collected using a scan speed of 400 Hz and 8 frame aver-
aging. Nuclei were detected using 4,6-diamidino-2-phenylindole
(DAPI)  (Vectashield) (excitation: 405 nm,  emission: 400–450 nm).
DNA was detected via TOTO-3 (Dimeric Cyanine Nucleic Acid
Stains–Invitrogen) (excitation: 642 nm,  emission and emission:
660 nm). PLL was detected via Oregon Green 488 (Invitrogen) (exci-
tation: 488 nm,  emission 524 nm)  and cell labelling was detected
by HCS CellMaskTM (Invitrogen) (excitation: 556 nm, emission:
572 nm).
To  quantify uptake approximately 30 cells from each slide were
randomly selected under the DAPI ﬁlter and the number of cell
associated polyplexes were counted and classiﬁed on the basis of
their intracellular location (cell periphery, cytosol or nuclei of the
respective cell) using ImageJ software. The number of polyplexes
within each cellular compartment was expressed as a percentage
of the total number of polyplexes counted within the group of 30
cells. The number of cells (30) was  selected as this was found to be
statistically sufﬁcient for quantiﬁcation as recommended by pre-
vious studies [11,12]. Each experiment was  repeated in triplicate
as previously reported by Dhanoya et al. [9]. Slides were blinded
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Fig. 1. Classiﬁcation of polyplex cellular location in DCs. A: Linear-pDNA polyplexes. B: OC-pDNA polyplexes. C: SC-pDNA polyplexes. Individual components of polyplexes
were stained; (i) PLL, (ii) DNA, (iii) DC, (iv) nuclei and (v) overlay of ﬂuorescent images to show polyplex cellular location. A(v): periphery. B(v): cytosol. C(v): nuclear
association. Polyplexes (containing 2 g DNA) were prepared at charge ratios (ratio of PLL to DNA) of; +1.6 for SC- and OC-pDNA, and +5 for linear-pDNA. Scale bar represents
5 m. DCs were ﬁxed with paraformaldehyde, stained and coverslips were mounted on slides.
Fig. 2. Quantiﬁcation of polyplex uptake in DCs in various cellular compartments. A: Confocal image quantiﬁcation at 1 h. B: Confocal image quantiﬁcation at 48 h. Polyplexes
(containing 2 g pDNA) were prepared at charge ratios (ratio of PLL to DNA) of; +1.6 for SC- and OC-pDNA, and +5 for linear-pDNA. The ﬁgure shows the mean and standard
error (SE) of 3 individual experiments (p < 0.05).
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(10–20 min  following uptake) the majority of polyplexes, regard-
less of DNA topology, were observed to be within the periphery of
DCs (Fig. 2a). However by 1 h uptake of SC-pDNA complexes was
Fig. 4. The effect of polyplex gene expression on DC phenotype. A: -galactosidase
expression  (FL1) in control (untransfected) and transfected (20 g DNA). B: Scatterig. 3. Polyplex gene expression within DCs. Polyplexes (containing 20 g pDNA) o
C-pDNA polyplexes and +5 for linear-pDNA polyplexes. The ﬁgure shows the mea
ith regard to experimental condition before counting to reduce
ossible bias.
.4.  DC phenotype measurements
Polyplexes  containing 20 g of pDNA were reverse transfected
nto DCs (approximately 1.9 × 106 cells per well). Cells were cul-
ured for a period of 48 h, and then detached from the PLL coated
overslips by gentle pipetting. Cells were washed and assayed
or -galactosidase activity via an ImaGene GreenTM C12FDG lacZ
ene Expression Kit (Invitrogen) according to the manufacturer’s
rotocol. Cells were then centrifuged and resuspended in PBS, to
hich 100 l was aliquoted to FACS tubes each containing 2 l
ntibodies for the following DC surface markers; IgG1, IgG2b,
D1a, DC-SIGN, CD11c, MHC-I, MHC-II, CD40, CD80, CD83 and
D86 (BD Pharmingen). Antibodies were ﬂuorescently labelled
ith phycoerythrin (PE) or allophycocyanin (APC). After 20 min
ncubation period at room temperature in the dark the cells
ere washed, resuspended in 300 l PBS and analysed by ﬂow
ytometry
.5. Statistical analysis
One-way  ANOVA was employed to deduce levels of statistical
igniﬁcance. Level of signiﬁcance selected was p = 0.05.
. Results and discussion
.1.  Qualitative and quantitative analysis of DC polyplex uptake
Polyplexes  (containing 2 g pDNA) were transfected into DCs
nd uptake was  monitored qualitatively by confocal microscopy
ver an initial 60 min  period (Fig. 1). Polyplexes were dual labelled
ith DNA stained red, while PLL was tagged green. DC cytosol
as stained light grey to highlight passage of polyplexes (using
ellMaskTM). Polyplexes were transfected at differing charge ratios
ratio of PLL to DNA) of +1.6 for SC- and OC-pDNA, and +5 for
inear-pDNA, as in Dhanoya et al. [9]. Dual staining was maintained
ndicating both DNA and PLL remained associated following uptake.
C-pDNA polyplexes were often observed to be associated with
he nuclei whereas OC- and linear-pDNA complexes were usually
ocated at the cell periphery indicating DNA topology may  inﬂuence
ptake (Fig. 1).
Polyplexes  in each cell were classiﬁed as being at the cell periph-
ry (Fig. 1a(v)), cytosol (Fig. 1b(v)) or nucleus (Fig. 1c(v)). If nolar surface charge were transfected, i.e. charge ratios of +1.6 employed for SC- and
 SE of 3 individual experiments (p < 0.05).
ﬂuorescent  overlap between the polyplex and the CellMaskTM
occurs, complexes are deﬁned as being at the cell periphery. If
some overlap between the polyplex and the CellMaskTM occurs,
complexes are classiﬁed as being in the cytosol. Complete over-
lap between polyplex and nuclear stain is classiﬁed as nuclear
association. Using these criteria the number and localisation of
cell associated polyplexes was counted and classiﬁed. Initiallyplots displaying the effect of polyplex gene expression on DC surface marker expres-
sion in transfected and nontransfected cells. -galactosidase expression (measured
in  FL1, y-axis) is plotted against cell surface marker expression (x-axis). C: -
galactosidase  positive and negative cells from transfected cultures were gated and
the expression of cell surface markers analysed.
A. Dhanoya et al. / Vaccine 30 (2012) 1675– 1681 1679
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cFig. 4. 
uch more efﬁcient, with 15% (±2.5% RSE) of complexes associ-
ted with the nuclei (polyplex ﬂuorescence overlaid with nuclear
tain). In contrast no nuclear association was observed for OC- and
inear-pDNA polyplexes, indicating topology dependent uptake.
ptake also showed dependence on DNA topology at longer peri-
ds (Fig. 2b). The optimum percentages observed were still small
ompared to previous studies with CHO cells [9] (61% [±1.67% RSE],nued ).
24.3[±2.72%  RSE] and 3.5% [±7.12% RSE] for SC-, OC-, and linear-
pDNA polyplexes).
DCs  are key sentinels of the immune system which engulf for-
eign antigens [13]. Nanoparticle uptake by DCs  has been reported
previously which led researchers to focus on polyplexes due to
similarity in size [14,15]. Our previous study regarding PLL/DNA
polyplexes reported sizes of 139.06 nm (±0.84% RSE), 305.54 nm
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±3.2% RSE) and 841.5 nm (±7.2% RSE) for SC-, OC- and linear-pDNA
olyplexes respectively [9], which are clearly within the size crite-
ion to be taken up by DCs (up to 1 m [14]). This may  account for
he uptake observed in Fig. 1.
.2. Polyplex gene expression in DCs shows dependence on DNA
opology
Uptake  of DNA does not necessarily correlate to gene expres-
ion, so reporter gene -galactosidase expression was measured
irectly. In this study complexes containing 20 g pDNA were
ransfected into DCs for 48 h to induce gene expression. Although
 g pDNA was used for confocal image studies, there was no signif-
cant difference between uptake proﬁles of complexes containing
 and 20 g (data not shown). Gene expression (lacZ reporter gene
ncoding -galactosidase) was highest for SC-pDNA polyplexes at
4% (Fig. 3). This was signiﬁcantly greater than OC- (9.59%) and
inear-pDNA polyplexes (7.43%) (p < 0.05).
The ability of SC-pDNA polyplexes to diffuse through cells more
fﬁciently than the other pDNA forms may  contribute towards
igher gene expression. We  previously reported how polyplexes
ontaining SC-pDNA displayed smaller sizes and greater nuclease
esistance than other DNA forms [9]. This is pivotal as DCs have
een found to express various nucleases [16]. Gene expression was
odest compared to a similar study with CHO cells [9], which
ay be due to premature phagocytic clearance thereby reducing
uclear uptake [15,17–19]. Other researchers have attempted to
mprove DC gene expression with immature DCs to increase cell
iability [17]. A mannosylating complex has been found to enhance
nteraction with DC surface receptors [20]. Block copolymer sys-
ems which shield, internalise and release DNA cargo can also
mprove gene expression [21]. However these systems are poly-
isperse (combination of polymers), are prone to aggregation and
an be cytotoxic at high polymer concentrations [21]. Non-viral
ene expression within DCs has been reported previously and sum-
arised in Table 1. With the exception of Landi et al. [17] and Faham
t al. [22], ﬁndings from Table 1 conﬁrm that non-viral DC gene
xpression is dependent on DNA dosage and the size of polyplex
sed. Although one study [23] employed pDNA doses of up to 10 g
ene expression was only 0.005%. This may  be due to the size of
uch complexes which ranged between 7 and 11.6 m (Table 1).
nother analysis [24] employed pDNA doses of >5 g and reported
0.05% gene expression. In the present study a dose of 20 g led
o up to 14% gene expression. A smaller dose of 10 g was also
sed; however this led to extremely low gene expression (data not
hown). This may  be due to the prevalence of nucleases within DCs
16] that degrade nucleic acids as previous gene expression studies
sing 10 g in CHO cells reported higher gene expression proﬁles
han complexes transfected into DCs [9]. This implies that at least
hree factors play a role in uptake and gene expression, these being;
ize, dosage and DNA topology. It is clear from this study that DNA
opology is an important parameter to consider for non-viral gene
elivery to DCs for vaccination strategies. For polyplex gene expres-
ion this study recommends the use of SC-pDNA when complexed
ith PLL.
.3.  The effect of polyplex gene expression on DC phenotype
DCs express various cell surface markers which contribute
owards antigen presentation [2]. Fig. 4 shows ﬂow cytometry
catter plots displaying the population of DCs and the level of
xpression of 9 surface markers following transfection of DNA poly-
lexes. SC-pDNA polyplexes were analysed, as these gave clear
istinguishable population of cells positive for -galactosidase that
an be detected by ﬂow cytometry (Fig. 4a). A comparison of
he bulk transfected and nontransfected populations showed no Ta
b
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vidence of increased expression of any of the markers (Fig. 4b).
-galactosidase expressing cells were gated, and the expression
f the cell surface marker on gated and non-gated cells was com-
ared directly (Fig. 4c). Markers such as DC-SIGN, which mediates
-cell activation [25] did not change with polyplex gene expres-
ion (Fig. 4c). This could be due to the low DNA dosage employed
hereby 20 g may  not be enough to pass a certain threshold to
licit phenotypic changes. Table 1 summaries how previous stud-
es employing similar DNA doses for non-viral DC gene delivery,
ailed to induce phenotypic changes, with the exception of one
tudy which employed up to 0.2 mg  DNA [22]. This suggests greater
NA dosage may  be required for DC activation. PEI/DNA complexes
ere also reported to fail in inducing DC phenotypic changes [21].
easuring such changes is important for clinical applications. Vac-
ines targeting DCs incorporate adjuvants that are designed to elicit
henotypic changes that activate DCs [21]. Therefore the ﬁndings
rom Fig. 4 reveal how PLL/DNA complexes could incorporate com-
onents (adjuvants) to induce DC activation. Alternatively by not
ctivating DCs, PLL/DNA polyplexes could display biocompatibility
llowing safe and effective nucleic acid delivery [21].
.  Conclusions
We  have shown that both uptake and gene expression (tran-
cription of reporter gene) of PLL/DNA polyplexes are dependent on
NA topology. Complexes containing SC-pDNA were most efﬁcient
n associating with the nucleus (polyplex ﬂuorescence overlaid
ith nuclear stain) as observed by confocal microscopy studies
15% [2.59% RSE] associated with the nucleus in comparison to
o nuclear association reported for OC- and linear-pDNA at 1 h).
owever confocal quantiﬁcation via ﬂuorescence overlay does not
irectly correspond to gene expression, as nuclear uptake of DNA
an still be hindered by the presence of nucleases [9]. Complexes
ontaining SC-pDNA displayed signiﬁcantly higher gene expression
14%) than other topological forms (9.59% and 7.43% for OC- and
inear-pDNA polyplexes) (p < 0.05), although expression was mod-
st in comparison to that reported for CHO cells [9]. This may  be due
o DCs predominately expressing nucleases which restrict uptake
nd gene expression. Lack of DC surface marker expression may  be
xplained by low dosage (20 g) used. This in itself may  be consid-
red advantageous in terms of biocompatibility and safe delivery
f DNA in vivo [21].
In  terms of bio-processing and vaccine production, the applica-
ion of SC-pDNA is a key pre-requisite. The ﬁndings of this study
how how pDNA in the SC conformation is more efﬁcient in terms
f both uptake and gene expression than OC- and linear-pDNA.
herefore DNA topology does impact on processing and vaccine
anufacture. This is in agreement with current regulatory bodies
uch as the FDA which require 80% SC content (Guidance for Indus-
ry: Considerations for Plasmid DNA Vaccines for Infectious Disease
ndications – FDA, 2007) [26].
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